Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country

Mostly true Certainty of evidence: moderate provisional C-PPI-11

PPIs are widely prescribed without a real indication (for example by doctors of other specialties to 'protect the stomach') and are now sold freely.

Conclusion: Largely correct: PPIs are overused and should be reviewed, though some 'protective' use is justified.
  1. Original statement
  2. Scientific assessment
  3. In plain language
  4. Studies on this claim
  5. Regional context
  6. What applies in my country?
  7. References

Original statement

دكتور بتاع العضم وبيكتب الكونترلوك صح عشان هو عارف ان ده بيمنع الحمض او سمع عنه ان هو دو بيعالج الارتجاع وبيحمي المعده حسب وجهه نظره

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

PPIs are widely prescribed without a real indication (for example by doctors of other specialties to 'protect the stomach') and are now sold freely.

Origin

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
الحلقة الثالثة من بودكاست #بدون_إثـــــــارة_جدل مع الدكتور ضياء العوضي (Open source)
Published
7 December 2024
Timestamp
0:02:23 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Machine-generated or CC transcript of a live stream; wording may contain transcription errors; context is conversational.
Claimed mechanism

Routine 'gastroprotection' and over-the-counter availability.

Claimed health effect

Unnecessary exposure.

Population concerned

General population.

Geographic restriction by Elawady

none found

Diverging source versions

انا في 2004 حضرت مثبطات المناعه اللي هي النهارده برشام بقى عادي اللي هو مثبطات الحموضه الكونترولوك والنكسيام والحاجات والبيبلوك والبيبتيوك وكل اللوك ده اللي هو بينزلوها دلوقتي من غير روشته ولا اي حاجه الدوا ده 2004 ما كانش عارف يدخل البلد ولا عارف يمشي فبقوا يجولنا احنا في الرعايه شغلوه بدا وحطوه بدل الزنتاك الزنتاج ده برض حاجه شبهه بس كان اقل فعاليه لان هو ما كانش بيقفل الحمض قوي بس ومع ذلك كانوا يكتبوا في الروشي بتاعته بيجيب اضطرابات هرمونيه ما كانش حد فاهم ليه بياثر على الذكوره بيقلل الرغبه الجنسيه ده فين ده في نشط الزنتان طب ايه اختلاف الزنتاك عن الكونترلاك او عند النكسيم اهو نفس الفكره انا هقفل حمض المعده بقى يبقى الموضوع لازم تربطه لي بحاجه اقول لك لا لا اصل المولكيول ده غير ده اصل الميكانزم ده غير ده يا باشا الاند الاند ريزلت انا بقفل الحمض فسنه 2004 اما تيجي تحسبها دلوقتي 2026 شوف في ال 20 سنه 22 سنه تضاعف حالات السرطان وضعف الانتصاب وسرطانات البروستاتا

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
بودكاست قبل رمضان (Open source)
Published
17 February 2026
Timestamp
0:52:55 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)

Scientific assessment

Mostly true – Correct at its core, but with limitations or minor inaccuracies.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

PPIs are over-prescribed.

2. What is demonstrably correct?

Correct in substance: AGA 2022 notes that PPIs 'are being used increasingly for indications where their benefits are less certain' and recommends regular review of the indication and de-prescribing where none exists.

3. What is wrong or exaggerated?

Not every co-prescription is unjustified: in people at high risk of ulcer bleeding from NSAIDs, a PPI is recommended (AGA 2017 BPA 5).

4. What remains unclear?

No Egyptian prescribing data were reviewed.

5. Which studies support it?

AGA 2022 (I-PPI-04), Farrell 2017 (I-PPI-05).

6. Which studies contradict it?

AGA 2017 BPA 5 (I-PPI-03).

7. What applies to Germany and Europe?

Over-prescription of PPIs is also discussed in Germany and Europe.

8. What is known about Egypt?

No local data reviewed.

9. What practical conclusion is appropriate?

Asking 'why am I taking this and for how long?' is good practice.

Assessment details

Rationale for certainty of evidence

Guidelines and expert reviews (AGA 2022, Farrell 2017) state that PPIs are increasingly used where benefit is uncertain and recommend regular review and de-prescribing; exact prescribing rates in Egypt were not reviewed.

Source quality

Video statement consistent with guideline concerns.

Regional transferability

Concern applies in Europe as well.

Individual exceptions

Some 'protective' prescriptions are justified (high-risk NSAID or antiplatelet users).

Regional scope of the claim
not specified
Last reviewed
25 October 2026 provisional

In plain language

Doctors' organisations agree that acid blockers are often given when they are not really needed. They recommend checking regularly whether a person still needs the drug and stopping it if not. At the same time, some people, for example those at risk of stomach bleeding from painkillers, do benefit.

Studies on this claim

Studies supporting the claim (2)

  • How to stop PPIs safely (AGA 2022)

    Targownik LE et al.. Gastroenterology 2022 · PMID 35183361 · DOI 10.1053/j.gastro.2021.12.247
    Guideline / position statementindependent cross-checkabstract only checked★ key study

    Stop PPIs without a definite indication; keep them in Barrett's, severe oesophagitis and high bleeding risk; expect temporary rebound.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    De-prescribing guidance.

    How was the study done?

    Expert review.

    What was actually found?

    10 statements.

    What do the results mean in everyday life?

    Many people can stop; some must not.

    What are the study's limitations?

    Expert opinion.

    What does it say about Elawady's specific claim?

    Supports overuse claim; contradicts universal ban and 'cannot stop'.

    Do the results apply to Germany and Europe?

    Applicable.

    Scientific details →

  • Canadian guideline for stopping PPIs

    Farrell B et al.. Can Fam Physician 2017 · PMID 28500192
    Guideline / position statementindependent cross-checkabstract only checked

    PPIs can be reduced or stopped in many patients, but not in Barrett's, severe oesophagitis or after bleeding ulcers.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Deprescribing.

    How was the study done?

    GRADE guideline.

    What was actually found?

    Deprescribe eligible patients.

    What do the results mean in everyday life?

    Stopping is possible.

    What are the study's limitations?

    Abstract only.

    What does it say about Elawady's specific claim?

    Contradicts 'cannot stop' and universal ban.

    Do the results apply to Germany and Europe?

    Applicable.

    Scientific details →

Studies contradicting or limiting the claim (0)

No studies in this group.

Studies with mixed or unclear results (1)

  • AGA advice on long-term PPIs

    Freedberg DE et al.. Gastroenterology 2017 · PMID 28257716 · DOI 10.1053/j.gastro.2017.01.031
    Guideline / position statementindependent cross-checkabstract only checked

    PPIs are justified for defined indications; risks do not require routine monitoring.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Risk–benefit guidance.

    How was the study done?

    Expert review.

    What was actually found?

    10 best practice statements.

    What do the results mean in everyday life?

    Use for real indications at lowest dose.

    What are the study's limitations?

    Expert opinion.

    What does it say about Elawady's specific claim?

    Mixed: supports indication-based use.

    Do the results apply to Germany and Europe?

    Applicable.

    Scientific details →

Regional context

Germany / EU

Over-prescription of PPIs is also discussed in Germany and Europe.

Egypt

No local data reviewed.

What applies in my country?

General scientific assessment

Mostly true Largely correct: PPIs are overused and should be reviewed, though some 'protective' use is justified.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

  1. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.. Targownik LE et al.. Gastroenterology 2022 · PMID 35183361 · DOI 10.1053/j.gastro.2021.12.247
  2. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.. Farrell B et al.. Can Fam Physician 2017 · PMID 28500192
  3. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.. Freedberg DE et al.. Gastroenterology 2017 · PMID 28257716 · DOI 10.1053/j.gastro.2017.01.031

← Back to overview